Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-26 | Dr. Hayden is a Killam Professor at the University of British Columbia and the Director of the Translational Laboratory in Genetic Medicine at the National University of Singapore and the Agency for Science, Technology and Research (A*STAR). From 2012 to 2017, he served as the President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical Industries Ltd. |
| 2022-04-20 | Dr. Hayden is also a Killam Professor at the University of British Columbia... He was the President of Global R&D and Chief Scientific Officer at Teva Pharmaceuticals... The Board believes Dr. Hayden is uniquely suited to serve on the Board because he has significant expertise in pharmaceutical research and development, both in academia and in commercial settings. |
| 2024-04-25 | Dr. Hayden has significant expertise in pharmaceutical research and development, both in academia and in commercial settings. He has founded five biotechnology companies and has been the recipient of numerous prestigious honors and awards. |
Data sourced from SEC filings. Last updated: 2025-08-30